Fundraising Fox

US Biologic

Memphis, US · Tennessee corporation · 1 known investors

US BIOLOGIC develops orally delivered vaccines for disease prevention, applying partner technologies to its oral-delivery platform for wildlife, companion animals, food animals, and humans. The company handles funding, regulatory support, manufacturing, and distribution to commercialize these preventative products.

Founders & leadership

MKMason Kauffman
Mason KauffmaninExecutive
MS
Michael ShmerlingNamed on SEC filing
TM
Thomas MonathNamed on SEC filing
TT
Tommy ThompsonNamed on SEC filing
DW
David WilliamsNamed on SEC filing
CP
Chris PrzybyszewskiinNamed on SEC filing
MG
Maria Gomes-SoleckiSenior Advisor / Inventor of US Biologic's first oral vaccination technology

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2017

$1MraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ShmerlingDirector
  • Thomas MonathDirector
  • Mason KauffmanExecutive Officer, Director
  • Tommy ThompsonDirector
  • David WilliamsDirector
  • Chris PrzybyszewskiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1M
First sale
Sep 2017
Incorporated
Corporation, Tennessee
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with US Biologic for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of Agriculture (USDA)Phase II2016$598.5K
Department of Agriculture (USDA)Phase I2015$98.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does US Biologic do?
US BIOLOGIC develops orally delivered vaccines for disease prevention, applying partner technologies to its oral-delivery platform for wildlife, companion animals, food animals, and humans. The company handles funding, regulatory support, manufacturing, and distribution to commercialize these preventative products.
Who are US Biologic's investors?
US Biologic's investors include Launch Tennessee.
How much funding has US Biologic raised?
US Biologic has disclosed $1M raised across 1 round.
Where is US Biologic headquartered?
US Biologic is headquartered in Memphis, US.